FIELD: medicine. SUBSTANCE: method involves determining prostaglandin E2 contents in blood plasma of a patient suffering from hemorrhagic fever aggravated with renal syndrome. The value being lowered to 18.19-26.18 pg/ml, the disease severity is evaluated as severe. The value is lowered to 28.84- 57.25 pg/ml, the disease severity is evaluated as moderate. The value being lowered to 100.0-113.0 pg/ml, the disease severity is evaluated as mild. EFFECT: high accuracy of method. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SEVERITY ASSESSMENT FOR HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2009 |
|
RU2392858C1 |
METHOD FOR EVALUATING GRAVITY OF CONDITION OF PATIENTS AFFECTED WITH HEMORRHAGIC FEVER COMPLICATED WITH NEPHRITE SYNDROME | 1993 |
|
RU2104533C1 |
METHOD OF PREDICTING DEVELOPMENT OF COMPLICATIONS OF HEMORRHAGIC FEVER WITH RENAL SYNDROME IN EARLY PERIOD OF DISEASE | 2010 |
|
RU2433407C1 |
METHOD FOR EVALUATING THE SEVERITY OF HEMORRHAGIC FEVER FLOW ACCOMPANIED WITH RENAL SYNDROME | 2003 |
|
RU2245552C1 |
METHOD OF TREATING HAEMORRHAGIC FEVER WITH RENAL SYNDROME | 2008 |
|
RU2379034C1 |
METHOD TO TREAT HEMORRHAGIC FEVER AT RENAL SYNDROME | 2000 |
|
RU2181046C2 |
METHOD FOR TREATMENT OF HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2002 |
|
RU2228196C1 |
METHOD FOR TREATMENT OF PATIENTS WITH HEMORRHAGIC FEVER WITH RENAL SYNDROME IN CASE OF LIVER DYSFUNCTION DEVELOPMENT | 2016 |
|
RU2645067C1 |
METHOD FOR PREDICTION OF SEVERE HAEMORRHAGIC FEVER WITH RENAL SYNDROME AT EARLY STAGES OF DISEASE | 2022 |
|
RU2790962C1 |
METHOD OF PREPARING PREPARATION FOR PROPHYLAXIS AND TREATMENT OF HEMORRHAGIC FEVER WITH RENAL SYNDROME | 1992 |
|
RU2063234C1 |
Authors
Dates
2000-08-27—Published
1998-12-09—Filed